PIPERNO, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 18.836
AS - Asia 7.759
EU - Europa 7.594
SA - Sud America 1.157
AF - Africa 113
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 35.478
Nazione #
US - Stati Uniti d'America 18.447
SG - Singapore 3.086
CN - Cina 2.134
HK - Hong Kong 1.370
RU - Federazione Russa 1.302
SE - Svezia 1.084
DE - Germania 1.061
IE - Irlanda 962
BR - Brasile 931
IT - Italia 872
UA - Ucraina 846
GB - Regno Unito 448
VN - Vietnam 436
CA - Canada 318
FI - Finlandia 262
FR - Francia 201
IN - India 151
AT - Austria 150
KR - Corea 99
AR - Argentina 89
TR - Turchia 82
NL - Olanda 78
BD - Bangladesh 65
BE - Belgio 62
JP - Giappone 61
DK - Danimarca 58
ID - Indonesia 56
PL - Polonia 48
ZA - Sudafrica 47
MX - Messico 43
IQ - Iraq 41
ES - Italia 36
PK - Pakistan 33
PE - Perù 29
BG - Bulgaria 28
EC - Ecuador 28
LT - Lituania 23
CO - Colombia 22
SA - Arabia Saudita 21
VE - Venezuela 18
CL - Cile 17
IR - Iran 15
PY - Paraguay 15
UZ - Uzbekistan 14
MA - Marocco 13
KE - Kenya 12
RO - Romania 12
DO - Repubblica Dominicana 11
EG - Egitto 10
AU - Australia 9
CH - Svizzera 9
CZ - Repubblica Ceca 9
MY - Malesia 9
NP - Nepal 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 8
IL - Israele 8
KZ - Kazakistan 8
TN - Tunisia 8
TW - Taiwan 8
EU - Europa 6
GR - Grecia 6
AM - Armenia 5
BO - Bolivia 5
ET - Etiopia 5
NO - Norvegia 5
AZ - Azerbaigian 4
CR - Costa Rica 4
HR - Croazia 4
JO - Giordania 4
KG - Kirghizistan 4
PT - Portogallo 4
BA - Bosnia-Erzegovina 3
HU - Ungheria 3
LB - Libano 3
MD - Moldavia 3
OM - Oman 3
PH - Filippine 3
RS - Serbia 3
SC - Seychelles 3
TH - Thailandia 3
UY - Uruguay 3
AL - Albania 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GE - Georgia 2
JM - Giamaica 2
KH - Cambogia 2
LK - Sri Lanka 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BH - Bahrain 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
GD - Grenada 1
Totale 35.454
Città #
Ann Arbor 3.013
Singapore 1.799
Woodbridge 1.748
Ashburn 1.464
Fairfield 1.438
Hong Kong 1.360
Houston 1.344
Chandler 1.026
Dublin 929
Jacksonville 909
Wilmington 751
Frankfurt am Main 651
Seattle 578
Dearborn 565
Cambridge 514
New York 401
Princeton 361
Santa Clara 341
Beijing 336
Milan 267
Nanjing 236
Los Angeles 235
Dallas 188
Hefei 185
Shanghai 183
Lawrence 174
The Dalles 163
Lachine 155
Altamura 134
Vienna 126
Ho Chi Minh City 113
Moscow 112
Buffalo 101
Chicago 100
São Paulo 94
San Diego 93
Seoul 91
Hanoi 86
Nanchang 75
Munich 73
Council Bluffs 70
Andover 67
Guangzhou 66
Shenyang 65
Helsinki 58
Hebei 54
Toronto 54
Brussels 52
Jinan 48
Boardman 47
Dong Ket 47
Changsha 46
London 46
Ottawa 44
Jakarta 41
Tianjin 41
Turku 40
Jiaxing 39
Rio de Janeiro 38
Tokyo 37
Falls Church 36
Salt Lake City 34
Brooklyn 33
Zhengzhou 33
Belo Horizonte 32
Phoenix 31
Warsaw 31
Montreal 30
Nuremberg 30
San Jose 30
Rome 27
Columbus 26
Mountain View 24
Norwalk 24
Boston 23
Denver 23
Fremont 23
Ningbo 23
Johannesburg 22
Orem 21
Plovdiv 21
Tampa 21
Huizen 19
Poplar 19
Stockholm 19
Turin 19
Campinas 18
Curitiba 18
Hangzhou 18
Kunming 18
Philadelphia 18
Chennai 17
Elk Grove Village 17
Mexico City 17
Atlanta 16
Auburn Hills 16
Brasília 16
Dhaka 16
Porto Alegre 16
Chengdu 15
Totale 24.422
Nome #
Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: A randomized clinical trial 600
Hepcidin regulation in a mouse model of acute hypoxia 536
Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia 382
GNPAT rs11558492 is not a major modifier of iron status: Study of Italian hemochromatosis patients and blood donors 362
Serum ferritin and liver features in a cohort of 15 patients affected by Gaucher disease 356
A severe hemojuvelin mutation leading to late onset of HFE2-hemochromatosis 334
Re-evaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome 333
Hif1a: A putative modifier of hemochromatosis 325
Juvenile Hemochromatosis 317
Inherited iron overload disorders 300
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 291
Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy 289
Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes 284
Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2 279
Novel mutations of the ferroportin gene (SLC40A1): Analysis of 56 consecutive patients with unexplained iron overload 278
Transferrin receptor 2 mutations in patients with juvenile hemochromatosis phenotype 278
Idiopathic erythrocytosis: a germline disease? 277
Hepcidin regulation in a mouse model of acute hypoxia 274
Type 3 hemochromatosis and beta-thalassemia trait 272
Circulating factors are involved in hypoxia-induced hepcidin suppression 272
The presence of two or more metabolic alterations and hepatic steatosis characterizes the dysmetabolic iron overload syndrome 272
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 269
Unexplained isolated hyperferritinemia without iron overload 263
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload 260
Early impairment of large artery structure and function in Type I diabetes mellitus 260
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients 251
Hyperferritinemia and diagnosis of type 1 Gaucher disease 251
Mental well-being in patients with transfusion-dependent anemias and hemochromatosis during the SARS-CoV-2 pandemic 250
Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia? 249
Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors 246
Heterogeneity of iron overload: Clinical, biochemical, histopathologic and genetic study of 70 patients 240
Hepatocellular carcinoma in Gaucher disease: an international case series 240
Atypical phenotype in a patient with ceruloplasmin mutations in the compound heterozygous state 238
Hepcidin expression in iron overload diseases is variably modulated by circulating factors 235
Iron Overload Increases Sympathetic Nervous Activity: Study in Hemochromatosis Patients at Diagnosis and Iron Depletion 235
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project 234
Dysmetabolic Hepatic Iron Overload Syndrome: Analysis of Hepcidin Response to Acute Oral Iron and Chronic Iron Overload 234
Prevalence of HFE mutations in upper northern Italy: study of 1132 unrelated blood donors 233
Ferroportin disease: A novel SLC40A1 mutation 231
Effects of venesections and restricted diet in patients with the Insulin-resistance hepatic iron overload syndrome 229
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 228
Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis 227
Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome 226
Ceruloplasmin variants might have different effects in different iron overload disorders 226
Increased serum ferritin is common in men with essential hypertension 224
Reduced expression of hepcidin in patients with myelodysplastic syndrome and myelofibrosis: the causes might be more heterogeneous than in thalassaemia. 223
S65C frequency in Italian patients with hemochromatosis, porphyria cutanea tarda and chronic viral hepatitis with iron overload 221
Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia 220
Angiotensin converting enzyme insertion/deletion polymorphism is related to pressor response to high altitude hypoxia. results of highcare project 219
UNEXPLAINED ISOLATED HYPERFERRITINEMIA IN PATIENTS WITHOUT MUTATIONS IN FERRITIN GENE AND L-FERRITIN IRES REGIONS 218
A time course of hepcidin response to oral iron challenge in hfe and tfr2 hemochromatosis patients 218
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 217
Hypoadiponectinemia is associated with insulin resistance in patients with non-HFE related hepatic iron overload 216
Different cortical excitability profiles in hereditary brain iron and copper accumulation 216
Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract 215
IRON AND HYPOXIA LINK: DOWNREGULATION OF LUCIFERASE ACTIVITY OF HEPCIDIN PROMOTER BY HYPOXIC SERA IN HUH-7 CELLS 215
Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype 214
HFE and SLC40A1 polymorphisms in patients with unexplained iron overload 213
Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia 213
Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HEF-Hemochromatosis 211
Identification of novel mutations by targeted NGS panel in patients with hyperferritinemia 209
Prevalence of C282Y and E168X HFE mutations in an italian population of northern european ancestry 207
Higher than expected progranulin mutaiton rate in a case series of Ialian FTLD patients 207
Commentary 207
Homozygous deletion of HFE: The Sardinian hemochromatosis? 206
The iron status of Italian subjects with beta-thalassemia trait 205
The iron-hypoxia link: hepcidin has a central role in the response to acute and chronic exposure to hypobaric hypoxia. data from the highcare project 204
Biochemical and genetic defects underlying human congenital hypotransferrinemia 203
HLA typing in 67 Italian patients with idiopathic hemochromatosis and their relatives 202
Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: Its relationship to hepatic fibrosis, activity of the disease and iron overload 202
Analysis of Polymorphisms of Genes Regulating Hepcidin Transcription in Hfe-Hemochromatosis 202
Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders 201
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 200
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis 200
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure 197
Effects of hypobaric hypoxia at high altitude on humoral regulation of blood pressure and body fluids. results of highcare project 197
The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis 195
Immunohistochemical evaluation of a panel of monoclonal antibodies for the diagnosis of small cell lung cancer 192
Revisitation of a cohort of 482 Italian patients with hereditary hemochromatosis: Changes in the last three decades 192
Immunohistochemical evidence for a lack of ferritin in duodenal absorptive epithelial cells in idiopathic hemochromatosis 190
GNPAT rs11558492 is not associated to iron overload in Italian HFE p.C282Y homozygotes 190
Myelodysplastic Syndromes and Iron Chelation Therapy 190
Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia 190
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype 189
Association of hereditary spherocytosis and idiopathic hemochromatosis. A synergistic effect in determining iron overload 189
Erythrocyte ferritin in patients on chronic hemodialysis treatment 188
Erythrocyte ferritin in thalassemia syndromes 188
Oxidative stress and antioxidant defence mechanisms in response to chronic hypobaric hypoxia. Results of the HIGHCARE project 188
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension 188
Single breath-hold multiecho mri sequences (at 1.5t) for the simultaneous lipid quantification and t2*measurement in patients with increased serum ferritin levels 187
Natural history of juvenile haemochromatosis 185
Haemochromatosis in patients with β-thalassaemia trait 183
Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports 183
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis 181
Iron overload in subjects with beta-thalassaemia trait: role of idiopathic haemochromatosis gene 181
Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (c70r) 180
Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation 180
Iron accumulation in chronic hepatitis C: relation of hepatic iron distribution, HFE genotype, and disease course 178
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 176
Ferritin, metabolic syndrome and NAFLD: Elective attractions and dangerous liaisons 175
Totale 23.646
Categoria #
all - tutte 122.601
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.601


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.682 0 0 0 0 0 200 265 190 252 361 179 235
2021/20222.444 110 261 325 231 181 135 115 137 110 160 196 483
2022/20233.871 552 1.107 344 344 226 583 26 233 250 22 115 69
2023/20242.611 100 95 97 71 341 614 565 162 193 48 53 272
2024/20255.730 396 675 231 241 565 176 225 288 740 815 496 882
2025/20267.107 1.331 757 1.018 1.460 1.782 759 0 0 0 0 0 0
Totale 36.252